SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-342597
Filing Date
2017-11-14
Accepted
2017-11-14 16:23:16
Documents
4
Period of Report
2017-11-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d495064d8k.htm 8-K 17326
2 EX-99.1 d495064dex991.htm EX-99.1 10475
3 GRAPHIC g495064g32z72.jpg GRAPHIC 5304
4 GRAPHIC g495064img02.jpg GRAPHIC 7459
  Complete submission text file 0001193125-17-342597.txt   46719
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 171201880
SIC: 2834 Pharmaceutical Preparations